BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

543444

FABINO

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

FABINO ENTERPRISES LIMITED Share Price Update

As of the latest trading session, FABINO ENTERPRISES LIMITED share price is currently at ₹ 23, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 23.00 and ₹ 23.00. Over the past year, FABINO ENTERPRISES LIMITED has achieved a return of -14.17 %. In the last month alone, the return has been -9.73 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

FABINO ENTERPRISES LIMITED fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    4.80

  • P/E Ratio (TTM)

    36.51

  • Beta

    1.06

  • Book Value / share

    20.42

  • Return on equity

    3.08%

  • EPS (TTM)

    0.63

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    -0.07

info icon alternate text

FABINO ENTERPRISES LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2021 (Values in Cr)
Revenue 0.92
Operating Expense 0.00
Net Profit -0.07
Net Profit Margin (%) -7.60
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars JUN 2021 (Values in Cr)
Revenue 1.13
Operating Expense 1.11
Net Profit 0.01
Net Profit Margin (%) 0.88
Earnings Per Share (EPS) 0.11
EBITDA 0.03
Effective Tax Rate (%) 50.00
Particulars MAR 2025 (Values in Cr)
Revenue 18.04
Operating Expense 18.07
Net Profit 0.13
Net Profit Margin (%) 0.72
Earnings Per Share (EPS) 0.63
EBITDA 0.46
Effective Tax Rate (%) 50.00
Particulars MAR 2024 (Values in Cr)
Revenue 6.08
Operating Expense 6.02
Net Profit 0.05
Net Profit Margin (%) 0.82
Earnings Per Share (EPS) 0.23
EBITDA 0.11
Effective Tax Rate (%) 33.33
Particulars MAR 2023 (Values in Cr)
Revenue 3.36
Operating Expense 3.37
Net Profit 0.01
Net Profit Margin (%) 0.29
Earnings Per Share (EPS) 0.05
EBITDA 0.04
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 4.20
Operating Expense 4.14
Net Profit 0.05
Net Profit Margin (%) 1.19
Earnings Per Share (EPS) 0.22
EBITDA 0.10
Effective Tax Rate (%) 28.57
Particulars MAR 2021 (Values in Cr)
Revenue 3.06
Operating Expense 3.01
Net Profit 0.03
Net Profit Margin (%) 0.98
Earnings Per Share (EPS) 0.25
EBITDA 0.07
Effective Tax Rate (%) 25.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 20.02
ROE % 1.44
ROCE % 5.59
Total Debt to Total Equity 0.37
EBITDA Margin 2.22
Particulars MAR 2024 (Values in Cr)
Book Value / Share 19.73
ROE % 0.97
ROCE % 1.80
Total Debt to Total Equity 0.20
EBITDA Margin 0.62
Particulars MAR 2023 (Values in Cr)
Book Value / Share 19.59
ROE % 0.24
ROCE % 0.44
Total Debt to Total Equity 0.10
EBITDA Margin 1.49
Particulars MAR 2025 (Values in Cr)
Book Value / Share 20.42
ROE % 3.08
ROCE % 7.13
Total Debt to Total Equity 0.29
EBITDA Margin 2.55
Particulars MAR 2024 (Values in Cr)
Book Value / Share 19.80
ROE % 1.21
ROCE % 1.88
Total Debt to Total Equity 0.15
EBITDA Margin 1.81
Particulars MAR 2023 (Values in Cr)
Book Value / Share 19.59
ROE % 0.24
ROCE % 0.46
Total Debt to Total Equity 0.05
EBITDA Margin 1.49
Particulars MAR 2022 (Values in Cr)
Book Value / Share 19.54
ROE % 1.85
ROCE % 2.71
Total Debt to Total Equity 0.06
EBITDA Margin 2.62
Particulars MAR 2021 (Values in Cr)
Book Value / Share 10.86
ROE % 3.05
ROCE % 2.79
Total Debt to Total Equity 0.70
EBITDA Margin 2.29
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.24
Total Assets 17.65
Total Liabilities 17.65
Total Equity 4.20
Share Outstanding 2100000
Price to Book Ratio 1.20
Return on Assets (%) 0.34
Return on Capital (%) 1.02
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 15.35
Total Liabilities 15.35
Total Equity 4.14
Share Outstanding 2100000
Price to Book Ratio 0.00
Return on Assets (%) 0.23
Return on Capital (%) 0.66
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.24
Total Assets 5.01
Total Liabilities 5.01
Total Equity 4.11
Share Outstanding 2100000
Price to Book Ratio 1.53
Return on Assets (%) 0.21
Return on Capital (%) 0.24
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.21
Total Assets 13.00
Total Liabilities 13.00
Total Equity 4.28
Share Outstanding 2100000
Price to Book Ratio 1.20
Return on Assets (%) 1.01
Return on Capital (%) 2.24
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 9.49
Total Liabilities 9.49
Total Equity 4.15
Share Outstanding 2100000
Price to Book Ratio 0.00
Return on Assets (%) 0.50
Return on Capital (%) 0.95
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.24
Total Assets 5.01
Total Liabilities 5.01
Total Equity 4.11
Share Outstanding 2100000
Price to Book Ratio 1.53
Return on Assets (%) 0.21
Return on Capital (%) 0.24
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.58
Total Assets 4.62
Total Liabilities 4.62
Total Equity 4.10
Share Outstanding 2100000
Price to Book Ratio 1.39
Return on Assets (%) 1.01
Return on Capital (%) 1.13
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 2.25
Total Liabilities 2.25
Total Equity 1.30
Share Outstanding 1200000
Price to Book Ratio 0.00
Return on Assets (%) 1.33
Return on Capital (%) 1.87
Particulars MAR 2025 (Values in Cr)
Net Income 0.18
Cash from Operations 0.25
Cash from Investing -0.41
Cash from Financing 0.47
Net change in Cash 0.18
Free Cash Flow 0.53
Particulars MAR 2024 (Values in Cr)
Net Income 0.03
Cash from Operations -0.75
Cash from Investing -0.27
Cash from Financing 0.86
Net change in Cash -0.18
Free Cash Flow -0.52
Particulars MAR 2023 (Values in Cr)
Net Income 0.01
Cash from Operations -0.66
Cash from Investing -0.01
Cash from Financing 0.33
Net change in Cash -0.34
Free Cash Flow -0.65
Particulars MAR 2025 (Values in Cr)
Net Income 0.25
Cash from Operations 0.00
Cash from Investing -0.41
Cash from Financing 0.73
Net change in Cash 0.19
Free Cash Flow 0.29
Particulars MAR 2024 (Values in Cr)
Net Income 0.04
Cash from Operations -2.97
Cash from Investing -0.18
Cash from Financing 0.42
Net change in Cash -2.74
Free Cash Flow -2.85
Particulars MAR 2023 (Values in Cr)
Net Income 0.01
Cash from Operations -0.66
Cash from Investing -0.01
Cash from Financing 0.33
Net change in Cash -0.34
Free Cash Flow -0.65
Particulars MAR 2022 (Values in Cr)
Net Income 0.04
Cash from Operations -1.89
Cash from Investing -0.04
Cash from Financing 2.47
Net change in Cash 0.52
Free Cash Flow -1.85
Particulars MAR 2021 (Values in Cr)
Net Income 0.03
Cash from Operations -0.41
Cash from Investing -0.10
Cash from Financing 0.44
Net change in Cash -0.10
Free Cash Flow -0.32
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.55 13.29 1.78 249.44 30.00 / 68.00
BLISS GVS PHARMA LTD 156.60 15.52 1.57 1654.47 105.05 / 190.65
CIPLA LTD 1501.65 22.29 3.68 121298.96 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 275.65 7.76 2.23 811.27 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.55 17.69 5.14 249.44 30.00 / 68.00
AMRUTAJAN HEALTH LTD 724.70 38.43 6.41 2095.15 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9535.45 112.73 30.94 23838.63 6222.35 / 10653.05
BLISS GVS PHARMA LTD 156.60 23.44 1.56 1654.47 105.05 / 190.65

FABINO ENTERPRISES LIMITED shareholding pattern

Holding

Others
43.18%
Promoter Holdings
56.81%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Aditya Mahavir Jain 1100000.0 (52.38%) Shareholding of Promoter and Promoter Group
Nopea Capital Services Private Limited 99000.0 (4.71%) Public Shareholding
Vandana Jain 84000.0 (4.0%) Shareholding of Promoter and Promoter Group
Venkateshwara Industrial Promotion Co Limited 66000.0 (3.14%) Public Shareholding
S K Growth Fund Pvt Ltd 48000.0 (2.29%) Public Shareholding
Akshay Kothari 42000.0 (2.0%) Public Shareholding
Emrald Commercial Limited 36000.0 (1.71%) Public Shareholding
Chiragkumar Valani 30000.0 (1.43%) Public Shareholding
Pushpa Devi 24000.0 (1.14%) Public Shareholding
Monika Malik 24000.0 (1.14%) Public Shareholding
Varsha Chopra 24000.0 (1.14%) Public Shareholding
Sumita Singh Kadian 24000.0 (1.14%) Public Shareholding
Sumit Malik 21000.0 (1.0%) Public Shareholding
Shreya Jain 4000.0 (0.19%) Shareholding of Promoter and Promoter Group
Kamal Naini Jain 2800.0 (0.13%) Shareholding of Promoter and Promoter Group
Shanta Jain 2400.0 (0.11%) Shareholding of Promoter and Promoter Group

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

FABINO ENTERPRISES LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
23.00 -5.15 redarrow
red-green-graph indicator
0 Bearish
0 Bullish
  • 5 Days 0.00
  • 26 Days 0.00
  • 10 Days 0.00
  • 50 Days 0.00
  • 12 Days 0.00
  • 100 Days 0.00
  • 20 Days 0.00
  • 200 Days 0.00
23.00 PIVOT

First Support

23.00

First Resistance

23.00

Second Support

23.00

Second Resistance

23.00

Third Support

23.00

Third Resistance

23.00

RSI

37.31

ADX

16.35

MACD

0.00

Williams % R

-100.00

Commodity Channel Index (CCI)

-106.43

Date

2025-10-08

Week

3000.00

Same Day

3000.00

Month

6000.00

1 Year

1.07

3 Year

-0.43

Over 1 Month

-9.73%

down

Over 1 Year

-14.17%

down

Over 3 Months

-13.88%

down

Over 3 Years

-11.33%

down

Over 6 Months

-13.20%

down

Over 5 Years

0.00%

down

FABINO ENTERPRISES LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

FABINO ENTERPRISES LIMITED Share Price

Fabino Enterprises Limited is a growing pharmaceutical company promoted by Atul Kumar Jain. The Company was incorporated as 'Fabino Life Sciences Private Limited' on October 27, 2011 with the Registrar of Companies, Delhi and Haryana. Subsequently, the Company got converted to Public Limited Company and the name of Company was changed to 'Fabino Life Sciences Limited'. A fresh Certificate of Incorporation was issued on March 21, 2015 by the Registrar of Companies, Delhi.

The Company operate in the business of manufacturing, marketing of pharmaceutical, allopathic, herbal, veterinary, and other consumer products like, packing, trading, etc. The core business is marketing of pharmaceutical formulation & products in domestic market through its own distribution network and sales force under own brand name, getting Ayurvedic formulations manufactured through loan licensing facilities, packing, labeling etc. The Company export wellness and FMCG products like Coffee, Malt powder, Protein powder, Hair shampoo which are marketed by the Company.

The Company operate a manufacturing plant at Sonipat, Haryana. The Company manufactures and pack products and market approximately 70+ products in the domestic market and have a portfolio of FMCG products for Overseas Markets. These products are being marketed under the respective trademarks and brands like 'Fabino' and 'Keepshine'. Fabino brand market mostly all pharmaceutical products including Tablets, Ointments Syrups etc for various medical treatments in allopathic and certain herbal range. Keepshine brand market Shampoo and Hair Maintenance products. Most of the Company product range is manufactured by third party manufacturers on made to order basis as per instructions or as per the manufacturer. These products are then marketed by Company. The products under this category are tablets, capsules, soft gelatin capsules, Gel, syrups, suspension, injections, Vitamin -C tablets, coffee, tea, etc.

The Company has obtained registration and patents for various products at becoming a strong intellectual property owning company in the future. Some of these products are manufactured by company in house at the processing centre in Sonipat Haryana, some of the products are manufactured at contract manufacturing facility in Haryana and other product range is manufactured by third party manufacturers on made to order basis as per instructions.

The marketing and distribution network in India and overseas comprises a specialized team of Marketing Executives, which enables the Company Promoters to market products to over 12 states across India. The Company also market products to various hospitals and medical institutions through their channel partners in different states, which constitute an important channel for the distribution of products. The domestic marketing infrastructure consists of dedicated teams & individuals associated with the Company directly and as channel partners, which formulate marketing and promotional strategies for their products. The Company currently supply in the Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa , Jharkhand , parts of West Bengal, Andhra Pradesh and Nepal.

To provide a larger range of services, the Company has started a new division with manufacturing units for herbal and ayurvedic products. It undertakes third party herbal and food supplement product manufacturing orders. The Ayurvedic/ Herbal business operations are supported by loan licensing facilities which are approved by relevant authorities. The Company have been awarded a G.M.P Certification for following Good Manufacturing Practices of Ayurveda / Siddha/ Unnani drugs under 'Schedule T' of Drugs & Cosmetics Rules, 1945 in respect of various categories of Tablets, capsule, Oils, Syrups and Powder.

Fabino Company is an ISO 9001:2015 certified in recognition to quality standards and accredited with certifications pertaining to quality, health and safety standards. The quality policy is focused on fulfilling customer requirements through reliable products aimed at meeting all regulatory requirements and through continual improvement of quality management systems. The third party manufacturer products undergo a qualification process throughout the entire value chain to ensure that quality products are being provided to customers. The quality control programs involve subjecting the manufacturing processes and quality management systems to periodic reviews and observations for various periods. Further, the Company ensures that third party manufacturing facilities are accredited with necessary approvals and provide quality output for customers.

The Company raised money from public through IPO by issuing 9,00,000 Equity Shares aggregating to Rs 3.24 crore in January, 2022.

In 2023-24, the Company changed its main objects to prepare, marker, trade, import, export, improve, process, sell and carry on the business of canners, preservers, growers of fresh and/or preservable products of vegetables, fruits, herbs, flowers, drinks, fluids and other and generally to carry on the manufacturing of juices, powder (edible) drinks, beverages, pickles, masalas, mixtures, vinegars,
ketchups, gelatins, essences, table delicacies and other eatables.

2. To manufacture, market, trade, import, export, improve, sell, food products which inter alia include but is not limited to pickles, spices made of chilies, pepper, cloves, turmeric, vegetables, herbs and other food items derived from agricultural or farming activities.

3. To carry on in India and elsewhere all kinds of agriculture, horticulture and other allied activities and also to establish, develop, promote and aid in India and elsewhere business and industries connected with agriculture and horticulture and other allied activities.

Parent organization Indian Private
NSE symbol [-]
Founded 2011
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Fabino Enterprises Ltd?

Answer Field

Fabino Enterprises Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 23.00 as on Oct 08 2025 12:00 AM.

What is the Market Cap of Fabino Enterprises Ltd Share?

Answer Field

The market cap of Fabino Enterprises Ltd for NSE ₹ 0.00 & for BSE ₹ 4.80 as on Oct 08 2025 12:00 AM.

What is the 52 Week High and Low of Fabino Enterprises Ltd?

Answer Field

The 52 Week High and Low of Fabino Enterprises Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 38.96 and ₹ 22.80.

What is 1 year return for Fabino Enterprises Ltd?

Answer Field

The 1 year returns on the stock has been -14.17%.

What is the P/E Ratio of Fabino Enterprises Ltd Share?

Answer Field

As on Oct 08 2025 12:00 AM the price-to-earnings (PE) ratio for Fabino Enterprises Ltd share is 36.51.

What is the PB ratio of Fabino Enterprises Ltd Share?

Answer Field

As on Oct 08 2025 12:00 AM, the price-to-book (PB) ratio for Fabino Enterprises Ltd share is 20.42.

How to Buy Fabino Enterprises Ltd Share?

Answer Field

You can trade in Fabino Enterprises Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Fabino Enterprises Ltd Share on Bajaj Broking App?

Answer Field

To buy Fabino Enterprises Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Fabino Enterprises Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59